secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inmune Bio, Inc. (INMB)
CIK:        0001711754
Form:       8-K
Filed at:   2025-12-23T23:59:59+00:00
Accession:  0001213900-25-125282
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INmune Bio amends 1.35M April 2024 warrants; exercise price cut to $1.95, term extended to June 2026
--------------------------------------------------------------------------------

- Exercise price of 1,348,315 outstanding April 2024 warrants reduced to $1.95 per share.
- Warrant term extended to expire on June 30, 2026 (from earlier conditional triggers).
- Holders paid $0.05 per warrant ($67,416 total) as amendment consideration.
- Warrants were originally issued in April 2024 offerings (April 24 & 29, 2024).
- Amendment effective upon receipt of signed amendment and full consideration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025125282/0001213900-25-125282-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025125282/ea0270723-8k_inmune.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-125282

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer